Biogen has announced a $2 billion investment to upgrade and expand its North Carolina operations, emphasizing automation and artificial intelligence in its manufacturing capabilities. The move solidifies its role as the largest biotechnology employer in the state and positions the company for future pharmaceutical innovation.